Drug profile · INN
nystatin
MYCOSTATIN ORAL DROPS
nystatin (MYCOSTATIN ORAL DROPS) is a ergosterol sequestering agent. Associated with Lacuna Pharma Pty Ltd. Route of administration: topical. Current US regulatory status: approved.
Drug details — nystatin
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
nystatin (MYCOSTATIN ORAL DROPS) is a ergosterol sequestering agent. Associated with Lacuna Pharma Pty Ltd. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Ergosterol sequestering agent
Primary target: Ergosterol
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is nystatin?
nystatin (MYCOSTATIN ORAL DROPS) is a ergosterol sequestering agent. Associated with Lacuna Pharma Pty Ltd. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for nystatin?
MYCOSTATIN ORAL DROPS is a marketed brand name for nystatin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of nystatin?
nystatin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.